QuapoS 4 - ESOP | European Society of Oncology Pharmacy
Pharmacotherapy in Children and Adolescents: Oncology | SpringerLink
Evaluation of allogeneic Transplantation in Patients above the age of 60 years with High Risk Acute Myeloid Leukemia (ETAL-2)
Janus-Type Dendrimers Based on Highly Branched Fluorinated Chains with Tunable Self-Assembly and 19F Nuclear Magnetic Resonance Properties | Macromolecules
MATRIX / High-dose chemotherapy and autologous stem cell transplant or consolidating conventional chemotherapy in primary CNS ly
Evaluation of allogeneic Transplantation in Patients above the age of 60 years with High Risk Acute Myeloid Leukemia (ETAL-2)
Kriterien zur Bestimmung der zweckmäßigen Vergleichstherapie und Recherche und Synopse der Evidenz zur Bestimmung der zweckmä
Inhaled Medicines: Past, Present, and Future | Pharmacological Reviews
AGO_2022E_14_Supportive Care and Managment of Side Effects_MASTER_schwarz_final
The Use of Phospholipids to Make Pharmaceutical Form Line Extensions
Kriterien zur Bestimmung der zweckmäßigen Vergleichstherapie und Recherche und Synopse der Evidenz zur Bestimmung der zweckmä
AGO_2022E_14_Supportive Care and Managment of Side Effects_MASTER_schwarz_final
AGO_2022E_14_Supportive Care and Managment of Side Effects_MASTER_schwarz_final
20/2010, 16-31 October - Fachinformationsverbund "Internationale ...
Inhaled Medicines: Past, Present, and Future | Pharmacological Reviews
Folie 1
AGO_2022D_14_Supportive Therapie und NW-Management_REF
Kriterien zur Bestimmung der zweckmäßigen Vergleichstherapie und Recherche und Synopse der Evidenz zur Bestimmung der zweckmä
Identification of solubility-limited absorption of oral anticancer drugs using PBPK modeling based on rat PK and its relevance to human - ScienceDirect
Uwe M. Martens Editor Third Edition
Pharmacotherapy in Children and Adolescents: Oncology | SpringerLink
Pharmacotherapy in Children and Adolescents: Oncology | SpringerLink
Pharmacotherapy in Children and Adolescents: Oncology | SpringerLink
MATRIX / High-dose chemotherapy and autologous stem cell transplant or consolidating conventional chemotherapy in primary CNS ly
AGO_2022D_14_Supportive Therapie und NW-Management_REF
